These 173 leaders will help steer the firm as Wall Street readies for a potential flood of dealmaking, from M&A to IPOs.

Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...

The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...

The bulk of Morgan Stanley's new managing directors, or 46%, work for the investment bank.

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

Morgan Stanley closed $8.38 short of its 52-week high ($136.24), which the company achieved on November 25th.

Robert Chen and his team like strategies like direct indexing because they systematically tax loss harvest throughout the ...

Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...

Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...

Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.

Morgan Stanley assigned a new analyst to cover hot artificial intelligence stock Palantir Technologies, and the Wall Street ...